HSC-00189

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameHSC-00189
Drug Alias NameHSC00189HSC-00189
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Cadherin-6Anti-FOLR1DNA topoisomerase I inhibitors
TargetsCadherin-6Folate receptor alphaDNA topoisomerase I
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHaisco Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A